Design Therapeutics, Inc
Advertisement
Design Therapeutics, Inc. is a biopharmaceutical company based in Carlsbad, CA, that focuses on developing novel small molecule therapeutic candidates aimed at addressing serious genetic diseases with significant unmet medical needs. Utilizing its GeneTAC Gene Targeted Chimera platform, the company is dedicated to targeting the underlying causes of genetic disorders through a deep understanding of gene regulation.
The company is advancing a pipeline that prioritizes treatments for monogenic repeat expansion disorders, including Friedreich ataxia, Fuchs endothelial corneal dystrophy, myotonic dystrophy, and Huntington's disease. Design Therapeutics is committed to pioneering small molecule genomic medicine to offer functional cures for these conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement